PTX3 and cardiovascular disorder: PTX3 can be released by neutrophils early and by macrophages and endothelial cells in the late phase of myocardial infarcted patients (84) and there is evidence to suggest that the heart is a major site for PTX3 expression (85), which could contribute to its involvement in multiple cardiovascular disorders.